Andrea Götschi

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Barco, Davide Voci, Ulrike Held et al. · The Lancet Haematology · 2022 · 55 citations · Full text

Thrombosis, Symptomatic Outpatients, Cardiovascular Disease +10

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

Davide Voci, Andrea Götschi, Ulrike Held et al. · Thrombosis Research · 2022 · 20 citations · Full text

Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry

Adrian Ciurea, Andrea Götschi, Seraphina Kissling et al. · RMD Open · 2023 · 14 citations · Full text

Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry

Adrian Ciurea, Andrea Götschi, René Bräm et al. · RMD Open · 2023 · 14 citations · Full text